These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19584)

  • 1. Increase in the turnover of brain dopamine by stimulation of muscarinic receptors outside the dopamine nerve terminals.
    Andén NE; Wachtel H
    J Pharm Pharmacol; 1977 Jul; 29(7):435-7. PubMed ID: 19584
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine.
    Lehmann J; Langer SZ
    Brain Res; 1982 Sep; 248(1):61-9. PubMed ID: 6289994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-acetylcholine interaction in the striatum studied by microdialysis in the awake rat: some methodological aspects.
    Westerink BH; de Boer P; Damsma G
    J Neurosci Methods; 1990 Sep; 34(1-3):117-24. PubMed ID: 1979647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
    Zhou LW; Zhang SP; Connell TA; Weiss B
    J Pharmacol Exp Ther; 1993 Feb; 264(2):824-30. PubMed ID: 8094754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
    Witkin JM
    Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine.
    Bonanno G; Marchi M; Raiteri M
    Neuropharmacology; 1985 Mar; 24(3):261-4. PubMed ID: 3990922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that noradrenaline modulates the increase in striatal dopamine metabolism induced by muscarinic receptor stimulation.
    Weinstock M; Zavadil AP; Muth EA; Crowley WR; O'Donohue TL; Jacobowitz DM; Kopin IJ
    Eur J Pharmacol; 1980 Dec; 68(4):427-35. PubMed ID: 7202502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for presynaptic cholinergic receptors on dopaminergic terminals: degeneration studies with 6-hydroxydopamine.
    De Belleroche J; Lugmani Y; Bradford HF
    Neurosci Lett; 1979 Feb; 11(2):209-13. PubMed ID: 460689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain GABA, dopamine and acetylcholine interactions. 1. Studies with oxotremorine.
    Pérez de la Mora M; Fuxe K
    Brain Res; 1977 Oct; 135(1):107-22. PubMed ID: 912426
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinergic modulation of dopamine overflow in the rat neostriatum: a fast cyclic voltammetric study in vitro.
    Kudernatsch M; Sutor B
    Neurosci Lett; 1994 Nov; 181(1-2):107-12. PubMed ID: 7898747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency-dependent muscarinic receptor modulation of acetylcholine and dopamine release from rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1984 Apr; 229(1):98-104. PubMed ID: 6707949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic-dopaminergic synergism on retinal cyclic AMP formation.
    Brown JH; Rietow M
    Brain Res; 1981 Jun; 215(1-2):388-92. PubMed ID: 6266579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor-mediated regulation of OM-853-enhanced dopamine release in striatum of rat.
    Koda H; Hashimoto T; Kuriyama K
    Eur J Pharmacol; 1989 Mar; 162(3):501-8. PubMed ID: 2744083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

  • 16. Striatal muscarinic receptors: regulation by dopaminergic agonists.
    Ehlert FJ; Roeske WR; Yamamura HI
    Life Sci; 1981 May; 28(21):2441-8. PubMed ID: 7253832
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxotremorine- and atropine-induced changes of dopamine metabolism in the rat striatum.
    Javoy F; Agid Y; Glowinski J
    J Pharm Pharmacol; 1975 Sep; 27(9):677-81. PubMed ID: 241812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat.
    Nose T; Takemoto H
    Eur J Pharmacol; 1974 Jan; 25(1):51-5. PubMed ID: 4435012
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of facilitation and muscarinic or alpha-adrenergic inhibition of acetylcholine and noradrenaline secretion from peripheral nerves.
    Alberts P
    Acta Physiol Scand Suppl; 1982; 506():1-39. PubMed ID: 6293252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system.
    Andén NE
    J Pharm Pharmacol; 1974 Sep; 26(9):738-40. PubMed ID: 4155755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.